Enoxaparin Sodium Market

The global Enoxaparin Sodium market was valued at US$ 3132.6 million in 2022 and is projected to reach US$ 5349 million by 2029, at a CAGR of 7.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Enoxaparin sodium is an anticoagulant medication (blood thinner).It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein.It is also used during hemodialysis.
Enoxaparin Sodium Market aims to provide a comprehensive presentation of the global market for Enoxaparin Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enoxaparin Sodium. Enoxaparin Sodium Market contains market size and forecasts of Enoxaparin Sodium in global, including the following market information:

• Global Enoxaparin Sodium Market Revenue, 2018-2023, 2024-2032, ($ millions)
• Global Enoxaparin Sodium Market Sales, 2018-2023, 2024-2032, (K Units)
• Global top five Enoxaparin Sodium companies in 2022 (%)

Europe is the largest market of Enoxaparin Sodium, with about 60% market share, followed by North America with about 17% market share. Currently, there are many players in this market.Sanofi, Teva, Techdow (Hepalink), Fresenius Kabi, Rovi, Amphastar, Nanjing King-friend, Sandoz and some others are playing important roles in Enoxaparin sodium injection industry. Sanofi, Teva, Techdow (Hepalink), Fresenius Kabi and Rovi are the top 5 players of Enoxaparin Sodium, with about 85% market shares.
There are nine different dosage form of Enoxaparin Sodium. The market can be segmented into 20 mg/0.2mL, 30 mg/0.3mL, 40 mg/0.4mL, 60 mg/0.6mL, 80 mg/0.8mL, 100 mg/1mL, 120 mg/0.8mL, 150 mg/1mL, 300mg/3mL. 40 mg/0.4mL is almost the only used and efficient types and took 40% market share. By application, Hospital is the largest consumer group, with market share of 63%.
We surveyed the Enoxaparin Sodium manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Enoxaparin Sodium Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Enoxaparin Sodium Market Segment Percentages, by Type, 2022 (%)

• 40 mg/0.4mL
• 60 mg/0.6mL
• 80 mg/0.8mL
• 100 mg/1mL
• 20 mg/0.2mL
• 30 mg/0.3mL
• Others

Global Enoxaparin Sodium Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Enoxaparin Sodium Market Segment Percentages, by Application, 2022 (%)

• Hospital
• Clinic
• Other

Global Enoxaparin Sodium Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Enoxaparin Sodium Market Segment Percentages, By Region and Country, 2022 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Enoxaparin Sodium revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Enoxaparin Sodium revenues share in global market, 2022 (%)
Key companies Enoxaparin Sodium sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Enoxaparin Sodium sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:

• Sanofi
• Abbott
• Teva
• Amphastar Pharmaceuticals
• Sandoz (Novartis)
• Cipla
• Taj Pharma
• Biophar?Lifesciences
• Innovative Pharmaceuticals
• Emcure Pharma
• Wellona Pharma
• Salvavidas Pharmaceutical
• Techdow (Hepalink)
• SL Pharm
• Chengdu Baiyu Pharmaceutical
• Nanjing King-friend Biochemical
• Changzhou Qianhong Bio-phram
• Hebei Changshan Biochemical Pharmaceutical
• Suzhou Erye Pharmaceutical
• Hangzhou Jiuyuan Gene Engineering

Outline of Major Chapters:

• Chapter 1: Introduces the definition of Enoxaparin Sodium, market overview.
• Chapter 2: Global Enoxaparin Sodium market size in revenue and volume.
• Chapter 3: Detailed analysis of Enoxaparin Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
• Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
• Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
• Chapter 6: Sales of Enoxaparin Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
• Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
• Chapter 8: Global Enoxaparin Sodium capacity by region & country.
• Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
• Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
• Chapter 11: The main points and conclusions of the report.

To know more about market statistics, Download a FREE Sample copy